di-tert-butyl 2,2'-[[4-(aminoacetyl)-1,2-phenylene]bis(oxy)]diacetate hydrochloride

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: di-tert-butyl 2,2'-[[4-(aminoacetyl)-1,2-phenylene]bis(oxy)]diacetate hydrochloride
• 英文别名: tert-butyl 2-[4-(2-aminoacetyl)-2-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]phenoxy]acetate;hydrochloride
• 化学式: C₂₀H₂₉NO₇*ClH
• 分子量: 431.914
• InChiKey: AMBUUHVHHVOMLD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.69
• 重原子数：
  29
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  114
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  di-tert-butyl 2,2'-[[4-(aminoacetyl)-1,2-phenylene]bis(oxy)]diacetate hydrochloride 、 1-N-BOC-4-哌啶丙酸 在 N-甲基吗啉 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 作用下， 生成 [[4-[[N-[3-(piperidin-4-yl)propionyl]amino]acetyl]-o-phenylene]dioxy]diacetic acid
  参考文献：
  名称：

  Tetrahydrothienopyridine derivatives as novel GPIIb/IIIa antagonists

  摘要：

  The tetrahydrothienopyridine derivatives were derived from aminomethylcyclohexylcarboxylic acid as a lead moiety. Evaluation of the antiplatelet activity and receptor binding assay revealed that compound 1 (ME3277) was a novel and potent non-peptide and non-amidinophenyl GPIIb/IIIa antagonist. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/0960-894x(96)00476-3
• 作为产物：
  描述：

  3,4-二羟基-2'-氯苯乙酮 在 palladium on activated charcoal 盐酸 、 sodium azide 、 氢气 、 potassium carbonate 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 生成 di-tert-butyl 2,2'-[[4-(aminoacetyl)-1,2-phenylene]bis(oxy)]diacetate hydrochloride
  参考文献：
  名称：

  Tetrahydrothienopyridine derivatives as novel GPIIb/IIIa antagonists

  摘要：

  The tetrahydrothienopyridine derivatives were derived from aminomethylcyclohexylcarboxylic acid as a lead moiety. Evaluation of the antiplatelet activity and receptor binding assay revealed that compound 1 (ME3277) was a novel and potent non-peptide and non-amidinophenyl GPIIb/IIIa antagonist. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/0960-894x(96)00476-3

文献信息

• Contrast medium for thrombus formation
  申请人：Murakami Yoshihiro

  公开号：US20070189970A1

  公开（公告）日：2007-08-16

  It is intended to provide a contrast medium for thrombus capable of binding specifically to a thrombus, lowering background noise and thus improving the resolution in a contrast examination for thrombus formation; and a method of detecting a thrombus by using the same. A contrast medium for thrombus comprising, as the active substance, a substance obtained by labeling a compound capable of binding to GPIIb/IIIa which is selected from among compounds represented by the general formulae (I) to (IV) and physiologically acceptable salts thereof, and a method of detecting a thrombus by using the same.

  本发明旨在提供一种用于血栓的对比介质，该介质能够特异性地结合到血栓上，降低背景噪声，从而提高对血栓形成的对比检查的分辨率；以及使用相同的方法检测血栓的方法。该血栓对比介质包括一种作为活性物质的物质，该物质是通过标记一种能够结合到GPIIb/IIIa的化合物获得的，该化合物选自通式（I）至（IV）所代表的化合物及其生理上可接受的盐；以及使用相同的方法检测血栓的方法。
• CONTRAST MEDIUM FOR THROMBUS FORMATION
  申请人：Astellas Pharma Inc.

  公开号：EP1719529A1

  公开（公告）日：2006-11-08

  It is intended to provide a contrast medium for thrombus capable of binding specifically to a thrombus, lowering background noise and thus improving the resolution in a contrast examination for thrombus formation; and a method of detecting a thrombus by using the same. A contrast medium for thrombus comprising, as the active substance, a substance obtained by labeling a compound capable of binding to GPIIb/IIIa which is selected from among compounds represented by the general formulae (I) to (IV) and physiologically acceptable salts thereof, and a method of detecting a thrombus by using the same.

  本发明旨在提供一种血栓造影剂，该造影剂能够特异性地与血栓结合，降低背景噪声，从而提高血栓形成造影检查的分辨率；以及使用该造影剂检测血栓的方法。一种用于血栓的造影剂，其活性物质包括通过标记能与 GPIIb/IIIa 结合的化合物而获得的物质，该化合物选自通式（I）至（IV）所代表的化合物及其生理上可接受的盐，以及通过使用该物质检测血栓的方法。
• Contrast medium for thrombus detection
  申请人：Astellas Pharma Inc.

  公开号：EP2404899A1

  公开（公告）日：2012-01-11

  Disclosed is a contrast medium for thrombus which comprises, as an active substance, a substance obtained by labeling a compound capable of binding to glycoprotein IIb/IIIa or a physiologically acceptable salt thereof with a positron emitting isotope 11C, the compound being represented by the general formula (IV): wherein R9 represents a hydrogen atom or an amino protective group.

  本发明公开了一种血栓造影剂，作为一种活性物质，该造影剂包含一种通过用正电子发射同位素 11C 标记能与糖蛋白 IIb/IIIa 结合的化合物或其生理上可接受的盐而获得的物质，该化合物由通式（IV）表示： 其中 R9 代表氢原子或氨基保护基团。
• EP1719529
  申请人：——

  公开号：——

  公开（公告）日：——
• Tetrahydrothienopyridine derivatives as novel GPIIb/IIIa antagonists
  作者：Kiyoaki Katano、Eiki Shitara、Masaro Shimizu、Kazue Sasaki、Tomoaki Miura、Yasuko Isomura、Mami Kawaguchi、Shokichi Ohuchi、Takashi Tsuruoka

  DOI：10.1016/0960-894x(96)00476-3

  日期：1996.11

  The tetrahydrothienopyridine derivatives were derived from aminomethylcyclohexylcarboxylic acid as a lead moiety. Evaluation of the antiplatelet activity and receptor binding assay revealed that compound 1 (ME3277) was a novel and potent non-peptide and non-amidinophenyl GPIIb/IIIa antagonist. Copyright (C) 1996 Elsevier Science Ltd